Corning Incorporated (NYSE:GLW) today announced it has expanded its microcarrier product line for bioprocess scale-up with the addition of four new Corning® Microcarriers for large-scale vaccine and cell therapy manufacturing.
The four new microcarriers are offered with various surface treatments and coatings to enhance cell attachment, helping maximize cell yield and viability:
• Corning Synthemax® II Coating. The unique substrate creates a synthetic surface on the microcarriers for stem cell expansion. Low-concentration microcarriers are available for mesenchymal stem cell (MSC) applications. High-concentration microcarriers are available for induced pluripotent and stem cell (iPS/ES) applications.
• Corning CellBIND®. This surface treatment infuses the surface of the microcarriers with oxygen to improve cell attachment.
• Positive charge surface treatment.
• Collagen coating.
“Researchers today are pressed to more efficiently and effectively scale up their bioprocess production,” said Ken Ludwig, business manager, Bioprocess and Cell Therapy, Corning Life Sciences. “These newest Corning advancements build on our existing microcarrier product line and all of our scale-up technologies to provide a more advanced and broader range of options to do just that.”
The latest Corning microcarrier offerings are sterile, ready-to-use, and available as closed-system solutions. They can be used directly with bioreactors, are nonpyrogenic, and are made with USP Class VI polystyrene material to provide a consistent platform for improved results. The new products extend Corning’s ongoing scale-up offerings, joining Corning’s line of CellSTACK® and HYPERStack® scale-up vessels, the full range of spinner flasks, and advanced cell culture media solutions.
Corning Life Sciences will also feature Corning® Mini Bioreactors at the Bioprocess International Conference. Announced in April 2013, the Corning Mini Bioreactors consist of a Corning® 50 mL Centrifuge Tube with a vented cap, and are ideal for high-throughput process optimization for suspension cell culture.
Through acquisition and ongoing investment in research and development, Corning now offers a more comprehensive range of premium, innovative laboratory products, and solutions for a wide spectrum of life science applications. Corning’s trusted, quality brands, backed by technical expertise, provide researchers with better ways to advance their research from the beginning of their process to the end. The family of brands includes Corning®, FALCON®, PYREX®, Costar®, Axygen®, Gosselin™ and Corning cellgro®.
Corning Life Sciences continually brings new and innovative laboratory technologies to researchers worldwide and helps customers succeed by providing innovative, high-quality products and services including polymer science, biochemistry and molecular biology, glass melting and forming, surface modification, and characterization science.
The latest Corning microcarriers are now available in the United States, and will be available beginning this month worldwide. The Corning mini bioreactors are currently available to customers worldwide. To learn more about the new microcarriers for bioprocess scale-up, the Corning Mini Bioreactors, or any Corning Life Sciences products, please contact a customer service representative at 1-800-492-1110, toll free in the United States; (+1) 1-978-442-2200 internationally; or visit www.corning.com/lifesciences .
Forward-Looking and Cautionary Statements
This press release contains “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning’s financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the effect of global political, economic and business conditions; conditions in the financial and credit markets; currency fluctuations; tax rates; product demand and industry capacity; competition; reliance on a concentrated customer base; manufacturing efficiencies; cost reductions; availability of critical components and materials; new product commercialization; pricing fluctuations and changes in the mix of sales between premium and non-premium products; new plant start-up or restructuring costs; possible disruption in commercial activities due to terrorist activity, armed conflict, political or financial instability, natural disasters, adverse weather conditions, or major health concerns; adequacy of insurance; equity company activities; acquisition and divestiture activities; the level of excess or obsolete inventory; the rate of technology change; the ability to enforce patents; product and components performance issues; retention of key personnel; stock price fluctuations; and adverse litigation or regulatory developments. These and other risk factors are detailed in Corning’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.
About Corning Incorporated
Corning Incorporated ( www.corning.com ) is the world leader in specialty glass and ceramics. Drawing on more than 160 years of materials science and process engineering knowledge, Corning creates and makes keystone components that enable high-technology systems for consumer electronics, mobile emissions control, telecommunications and life sciences. Our products include glass substrates for LCD televisions, computer monitors and laptops; ceramic substrates and filters for mobile emission control systems; optical fiber, cable, hardware & equipment for telecommunications networks; optical biosensors for drug discovery; and other advanced optics and specialty glass solutions for a number of industries including semiconductor, aerospace, defense, astronomy, and metrology.